Connect With Us:
- Prova Education Series
- From Guideline to Practice: Managing Challenging Cases in Primary Care
- Interprofessional Management and Collaborative Care in Type 2 Diabetes Mellitus
- Acute Coronary Syndrome
- Atopic Dermatitis
- New Frontiers in Alzheimer's Disease
- A Focus on Age-Related Eye Disease
- Male Sexual Health: A Focus on Hypogonadism
- 2013 ACC/AHA Blood Cholesterol Guidelines
- Binge Eating Disorder: Optimizing Diagnosis and Management
- Controversial Guidelines for Breast Cancer Screening for Women at Average Risk
- Diagnosing and Managing Hospitalized Patients with Hyponatremia: Optimizing Outcomes
- Diagnosis and Management of Hyponatremia in Patients with SIADH
- Managing Hyponatremia in Patients with Cirrhosis
- Managing Hyponatremia in Patients with Heart Failure
- Project Oncology
- Clinician's Commentary
- Answers from the Experts
- Resources and References
The Changing Landscape of Alzheimer's Disease: Screening, Diagnosis and Management for Optimal Patient Outcomes
- November 10, 2012 7:30 AM to 10:00 AM
- Marriott Atlanta Buckhead Hotel & Conference Center
3405 Lenox Road NE
Atlanta, GA 30326
Click here for venue website
There is no charge for this event.
This CME activity is designed to improve knowledge, awareness, competencies and decision-making patterns relative to the diagnosis and management of Alzheimer’s disease. The curriculum will direct learners to the most current criteria and guidelines from the Alzheimer’s Association (AA), and the National Institute on Aging (NIA) of the National Institutes of Health (NIH) criteria and guidelines. Learners will discuss available and emerging treatments, and gain awareness of what is developing for the future of Alzheimer’s disease care from current clinical trials and literature. The case-based learning format is designed to improve performance in diagnosis and testing, as well as raise clinicians’ awareness of the latest technologies available to accomplish these tasks.
Number of Credits
Maximum of 2 AMA PRA Category 1 CreditsTM.
7:30 – 8:00 AM
Breakfast and Registration
8:00 – 8:10 AM
Welcome and Introductions
8:10 – 8:30 AM
New Diagnostic Guidelines for MCI and AD
8:30 – 8:50 AM
CSF and Imaging Biomarkers
8:50 – 9:10 AM
Case Histories and Discussion
9:10 – 9:30 AM
Update of Established and Emerging Treatments
9:30 – 10:00 PM
Panel Discussion with Question and Answer Session
William Hu, MD, PhD
Assistant Professor of Neurology
Emory University School of Medicine
James Lah, MD, PhD
Alice Richards Chair for Alzheimer's Disease
Associate Professor of Neurology Director of the Clinical Core of the Emory Alzheimer's Disease
Center Emory University School of Medicine
Allan Levey, MD, PhD
Professor and Chair of Neurology
Director, Emory Alzheimer's Disease Research Center
Emory University School of Medicine
Upon completion of this activity, participants should be able to:
- More confidently apply the new 2011 recommendations and guidelines, associated with the paradigm shift in diagnostic criteria, in order to improve patient outcomes
- Better evaluate the place of emergent biomarkers/imaging as a critical adjunct to earlier identification of AD, based on the new 2011 diagnostic criteria
- Incorporate into their clinical practice the changing treatment doctrine for AD, especially (though not exclusively) as newer classes of disease-modifying drug agents emerge from clinical trials of AD
This course is designed to meet the Continuing Medical Education needs of the practicing neurologist, radiologist, nuclear medicine professional, gerontologist, and primary care physician.
The Omnia-Prova Education Collaborative, Inc. (TOPEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Omnia-Prova Education Collaborative, Inc. designates this live activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support Statement
This activity is supported by an independent educational grant from Lilly USA, LLC.
Prova Education fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of support services, please notify Prova Education at 877.776.8211 a minimum of two weeks prior to the activity in order to ensure service.
Overnight Self-Parking: $20
Overnight Valet-Parking: $30
Prova Education does not offer a discount conference room rate. To make reservations please contact the hotel directly at 404-261-9250.
*subject to change
Do you have questions about an activity?
Call one of our knowledgeable customer service representatives for answers.